Investigation of CDH3 as a Diagnostic and Prognostic Biomarker in Lung Adenocarcinoma: An Integrative Analysis of Gene Expression, Promoter Methylation, and Clinical Significance
Background: LUAD constitutes the most prevalent type of lung cancer and one of the major causes of death due to malignancies worldwide. Identification of reliable molecular biomarkers will be crucial to improve diagnosis, prognosis and therapy for this disease. Objectives: This study will analyze the role of CDH3 gene...